Hemithyroidectomy for Differentiated Thyroid Cancer

[1]  Minerva A. Romero Arenas,et al.  Lobectomy Compared to Total Thyroidectomy for Low-Risk Papillary Thyroid Cancer: A Systematic Review. , 2019, The Journal of surgical research.

[2]  S. Roman,et al.  Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes. , 2019, Surgery.

[3]  Jae Hyun Park,et al.  Lobectomy in patients with differentiated thyroid cancer: indications and follow-up. , 2019, Endocrine-related cancer.

[4]  J. Yi,et al.  Transoral endoscopic thyroidectomy for thyroid carcinoma: outcomes and surgical completeness in 150 single-surgeon cases , 2019, Surgical Endoscopy.

[5]  Sun Wook Cho,et al.  Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer , 2019, Endocrinology and metabolism.

[6]  Hui Huang,et al.  Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis. , 2019, Oral oncology.

[7]  S. Sidhu,et al.  Risk of needing completion thyroidectomy for low‐risk papillary thyroid cancers treated by lobectomy , 2019, BJS open.

[8]  M. R. Kim,et al.  Transoral endoscopic thyroid surgery in a Korean population , 2019, Surgical Endoscopy.

[9]  Tae Yong Kim,et al.  Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer. , 2018, Thyroid : official journal of the American Thyroid Association.

[10]  C. Lubitz,et al.  Impact of Extent of Surgery on Tumor Recurrence and Survival for Papillary Thyroid Cancer Patients , 2018, Annals of surgical oncology.

[11]  R. Tuttle,et al.  A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management , 2018, Expert review of endocrinology & metabolism.

[12]  D. Winchester,et al.  CONCORDANCE OF PRE-OPERATIVE CLINICAL STAGE WITH PATHOLOGIC STAGE IN PATIENTS ≥45 YEARS OLD WITH WELL-DIFFERENTIATED THYROID CANCER. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  L. Yip,et al.  Correct extent of thyroidectomy is poorly predicted preoperatively by the guidelines of the American Thyroid Association for low and intermediate risk thyroid cancers , 2018, Surgery.

[14]  Tae Yong Kim,et al.  Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study. , 2017, Thyroid : official journal of the American Thyroid Association.

[15]  Q. Duh,et al.  Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine , 2017, Surgery.

[16]  Laura D. Scherer,et al.  Development of the Medical Maximizer-Minimizer Scale. , 2016, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[17]  R. Tuttle,et al.  Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine. , 2016, The Journal of clinical endocrinology and metabolism.

[18]  A. Miyauchi,et al.  A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma. , 2016, Thyroid : official journal of the American Thyroid Association.

[19]  R. Tuttle,et al.  A Risk-adapted Approach to Follow-up in Differentiated Thyroid Cancer , 2016, Rambam Maimonides medical journal.

[20]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[21]  S. Roman,et al.  Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival: An Analysis of 61,775 Patients , 2014, Annals of surgery.

[22]  R. Tuttle,et al.  Update on differentiated thyroid cancer staging. , 2014, Endocrinology and metabolism clinics of North America.

[23]  R. Tuttle,et al.  Thyroid Lobectomy Is Associated with Excellent Clinical Outcomes in Properly Selected Differentiated Thyroid Cancer Patients with Primary Tumors Greater Than 1 cm , 2013, Journal of thyroid research.

[24]  T. Uruno,et al.  Thyroid Lobectomy for Papillary Thyroid Cancer: Long-term Follow-up Study of 1,088 Cases , 2013, World Journal of Surgery.

[25]  J. Shah,et al.  Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. , 2012, Surgery.

[26]  R. Tuttle,et al.  Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer , 2011, Clinical endocrinology.

[27]  J. Tward,et al.  Overall and cause‐specific survival for patients undergoing lobectomy, near‐total, or total thyroidectomy for differentiated thyroid cancer , 2011, Head & neck.

[28]  J. Shah,et al.  Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer , 2011, Annals of Surgical Oncology.

[29]  Abie H. Mendelsohn,et al.  Surgery for papillary thyroid carcinoma: is lobectomy enough? , 2010, Archives of otolaryngology--head & neck surgery.

[30]  C. Ko,et al.  Extent of Surgery Affects Survival for Papillary Thyroid Cancer , 2007, Annals of surgery.

[31]  D. Urbach,et al.  Extent of Thyroidectomy Is Not a Major Determinant of Survival in Low- or High-Risk Papillary Thyroid Cancer , 2005, Annals of surgical oncology.

[32]  G. Daniels,et al.  Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. , 2002, Thyroid : official journal of the American Thyroid Association.